Tubulin Inhibitor 6 is primarily used in cancer research due to its ability to disrupt microtubule formation. Microtubules are essential for cell division, and by inhibiting their assembly, this compound effectively halts the proliferation of cancer cells. It is particularly valuable in studying the mechanisms of mitosis and identifying potential therapeutic targets for various cancers. Researchers also utilize it to explore drug resistance and develop more effective chemotherapy agents. Its application extends to preclinical studies, where it helps evaluate the efficacy and safety of new anticancer drugs.